Phospho-STAT4 (Y693) Antibody

What is the biological significance of STAT4 phosphorylation at Y693?

STAT4 phosphorylation at tyrosine 693 represents a critical activation event in the STAT4 signaling pathway. Upon cytokine receptor binding, particularly IL-12 or type 1 interferons (IFN-α, IFN-β), Janus kinases (JAKs) phosphorylate STAT4 at the Y693 residue. This phosphorylation triggers STAT4 homodimerization and subsequent nuclear translocation, where it binds to DNA and regulates transcription of specific genes in a cell type- and cytokine-specific manner .

The biological significance includes:

• Essential role in T-helper 1 (Th1) differentiation and function

• Critical for optimal interferon-gamma (IFN-γ) production

• Key mediator in immune responses against intracellular pathogens

• Important in multiple neutrophil functions including chemotaxis

• Participates in production of neutrophil extracellular traps

What applications are validated for Phospho-STAT4 (Y693) antibodies?

Phospho-STAT4 (Y693) antibodies have been validated for multiple applications with specific optimal dilutions:

For flow cytometry applications, Protocol C (Two-step protocol with Fixation/Methanol) is specifically recommended, while Protocol A (Two-step protocol for cytoplasmic proteins) and Protocol B (One-step protocol for nuclear proteins) are not suitable for this antibody .

How should I design stimulation experiments to induce and detect STAT4 phosphorylation?

Designing effective stimulation experiments for STAT4 phosphorylation requires careful consideration of cell types, stimuli, and timing:

Recommended stimulation conditions:

• IL-12 stimulation: Most potent inducer of STAT4 phosphorylation, particularly effective in T cells and NK cells

• Type I IFNs (IFN-α, IFN-β): Induces STAT4 phosphorylation with species-specific differences

• Pervanadate treatment: Commonly used as a positive control (demonstrated effectiveness at 5 minutes of treatment)

• Combined stimulation: IFN-α + IL-4 + pervanadate combination shows enhanced phosphorylation

Experimental protocol example:

• For human T cells: Isolate peripheral blood mononuclear cells, treat with IL-12 (10 ng/mL) for 15-30 minutes

• For NK cells: IL-2 treatment can induce STAT4 phosphorylation (unlike in T cells)

• For positive control: Treat cells with pervanadate for 5 minutes before lysate preparation

Important considerations:

• Phosphorylation is transient—optimize time points for your specific cell system

• Include both phospho-specific and total STAT4 antibodies in parallel samples

• Remember species differences: IFN-α phosphorylation of STAT4 is weaker and more transient in mouse T cells compared to IL-12, while in human CD4+ T cells, IFN-α effectively promotes Th1 development

What are the optimal protocols for detecting phosphorylated STAT4 via Western blot?

Western blotting for phospho-STAT4 (Y693) requires careful optimization to preserve phosphorylation status and maximize sensitivity:

Sample preparation:

• Rapidly lyse cells in buffer containing phosphatase inhibitors

• Maintain samples at 4°C throughout processing

• Use freshly prepared lysates when possible, or snap-freeze and store at -70°C

Protocol optimization:

• Antibody dilution: Use at 1:1000 dilution for optimal results

• Membrane type: PVDF membranes are recommended

• Secondary antibody: HRP-conjugated Anti-Rabbit IgG (e.g., HAF008)

• Expected band size: Look for specific band at approximately 81-95 kDa

• Buffer system: Use Immunoblot Buffer Group 1 for optimal results

• Controls: Include both unstimulated and stimulated samples (e.g., NC-37 human Burkitt's lymphoma B lymphoblast cells with/without pervanadate treatment)

Validation approach:
For complete validation, probe duplicate membranes with:

• Phospho-STAT4 (Y693) antibody for activated STAT4

• Total STAT4 antibody to confirm protein expression levels

This dual-detection approach allows normalization of phospho-signal to total protein and confirms specificity of the phospho-antibody.

How can Phospho-STAT4 (Y693) antibodies be utilized in chromatin immunoprecipitation (ChIP) experiments?

Chromatin immunoprecipitation with phospho-STAT4 antibodies enables direct investigation of activated STAT4 binding to target gene promoters:

Optimized ChIP protocol:

• Starting material: Use 10 μg of chromatin (approximately 4 × 10^6 cells) per IP

• Antibody amount: 20 μl of phospho-STAT4 (Y693) antibody per IP

• Methodology: Use enzymatic chromatin digestion for optimal results

• Controls: Include IgG control and positive control (known STAT4 target)

• Validation: SimpleChIP® Enzymatic Chromatin IP Kits have been validated with this antibody

Research applications:

• Identifying direct transcriptional targets of activated STAT4

• Investigating the kinetics of STAT4 binding following cytokine stimulation

• Examining cooperative binding with other transcription factors

• Assessing chromatin modifications at STAT4-regulated loci

Example findings from literature:
Research has revealed STAT4 binding to the MIR130A and MIR301A promoter regions, demonstrating a role for STAT4 in regulating microRNA expression in cancer cells . ChIP experiments can effectively map the exact binding sites, as shown by STAT4 binding to specific segments of these promoters.

What methodological approaches can distinguish STAT4-specific signaling from other STAT family members?

Distinguishing STAT4 signaling from other STAT family members requires careful experimental design:

Differentiation strategies:

• Specific stimulation conditions: IL-12 preferentially activates STAT4, while other cytokines differentially activate other STATs (e.g., IFN-γ for STAT1, IL-4 for STAT6)

• Temporal analysis: Monitor phosphorylation kinetics, as each STAT has distinct activation/deactivation timelines

• Genetic approaches: Use STAT4-specific knockdown/knockout models to confirm specificity

• Inhibitor studies: Use specific JAK inhibitors targeting different STAT activation pathways

Verification methods:

• Western blot analysis: Probe for multiple phospho-STATs (STAT1, STAT4, STAT6) on the same samples, as demonstrated in lung tissue samples after BMDC adoptive transfer

• Flow cytometry: Multi-parameter analysis with antibodies against different phospho-STATs

• Functional readouts: Measure STAT4-dependent outcomes (e.g., IFN-γ production) versus outcomes dependent on other STATs

Data interpretation example:
In a study of SOCS3-mediated inhibition of STAT signaling, researchers simultaneously assessed phosphorylation of STAT1, STAT4, and STAT6. Through densitometry analysis of Western blot results, they could distinguish the specific effect on each STAT pathway and determine which were significantly inhibited .

How can I optimize flow cytometry detection of phospho-STAT4 (Y693)?

Flow cytometric analysis of phospho-STAT4 requires specific optimization compared to surface marker detection:

Protocol recommendations:

• Fixation/permeabilization: Use Protocol C (Two-step protocol with Fixation/Methanol)

• Antibody amount: 5 μL (0.25 μg) per test in a final volume of 100 μL

• Cell number: Can range from 10^5 to 10^8 cells/test (determine empirically for your cell type)

• Controls required:

  • Unstimulated controls (e.g., untreated or imatinib-treated cells)

  • Stimulated positive controls (e.g., IFN-α + IL-4 + pervanadate treatment)

  • Isotype control antibody

Optimization tips:

• Stimulation timing: Critical for capturing peak phosphorylation

• Buffer formulation: Ensure phosphatase inhibitors are present

• Antibody titration: Verify optimal concentration for your specific cells

• Co-staining: Consider including lineage markers to identify responding populations

Example results interpretation:
Flow cytometric analysis of K562 cells shows distinct populations:

• Unstimulated imatinib-treated cells show minimal staining

• Stained cells treated with imatinib show slight shift

• Cells treated with IFN-α + IL-4 + pervanadate show strong positive shift, indicating STAT4 phosphorylation

What approaches can resolve contradictory results between different detection methods for phospho-STAT4?

When faced with conflicting results between different detection methods (e.g., Western blot versus flow cytometry), systematic troubleshooting is required:

Common causes of discrepancies:

• Method sensitivity differences: Flow cytometry may detect subtle changes in subpopulations that are diluted in whole-cell lysates

• Antibody epitope accessibility: Different fixation/permeabilization methods can affect epitope exposure

• Phosphorylation dynamics: Timing differences in sample processing can capture different phosphorylation states

• Cell heterogeneity: Western blot averages signals across all cells, while flow cytometry examines individual cells

Resolution strategies:

• Standardize stimulation conditions: Use identical stimulation protocols before both assays

• Cross-validate antibodies: Test multiple phospho-STAT4 antibody clones in both applications

• Cell sorting validation: Sort phospho-STAT4-positive and negative populations by flow cytometry, then confirm by Western blot

• Time-course analysis: Perform parallel temporal analysis with both methods to identify potential kinetic differences

Advanced approach:
When contradictory findings persist, consider utilizing phospho-flow cytometry combined with RNA-seq or single-cell Western blot to correlate STAT4 activation with downstream gene expression at the single-cell level, which can help resolve population heterogeneity issues.

How is Phospho-STAT4 (Y693) detection used in autoimmune disease and cancer research?

Phospho-STAT4 (Y693) detection has important applications in understanding pathological mechanisms:

Autoimmune disease applications:

• Experimental autoimmune encephalomyelitis (EAE): Studies demonstrate berbamine's immunomodulatory properties through selective down-regulation of STAT4 and action of IFN-gamma

• T-cell dysregulation: Investigating aberrant STAT4 activation in autoimmune conditions

• Therapeutic development: Screening compounds that modulate STAT4 phosphorylation as potential treatments

Cancer research applications:

• Ovarian cancer: Investigating STAT4 and YY1-mediated regulation of miR-130a and 301a expression in CD24-high ovarian cancer cells

• Burkitt's lymphoma: Using cell lines like NC-37 to study STAT4 activation mechanisms

• Breast carcinoma: IHC analysis of paraffin-embedded human breast carcinoma tissue shows presence of phosphorylated STAT4

Methodological approaches:

• Western blot analysis: For monitoring treatment effects on STAT4 phosphorylation status

• Chromatin immunoprecipitation: Identifying cancer-relevant target genes of activated STAT4

• Immunohistochemistry: Detecting phosphorylated STAT4 in patient-derived tumor samples

Example research finding:
In studies examining STAT4-dependent microRNA regulation in ovarian cancer, researchers used ChIP assays with anti-STAT4 antibodies to demonstrate direct binding to MIR130A and MIR301A promoters. This binding was further shown to be dependent on upstream signaling events involving Src and FAK .

What experimental approaches can investigate the differential effects of IL-12 versus type I IFNs on STAT4 phosphorylation?

Investigating the differential effects of IL-12 and type I IFNs on STAT4 phosphorylation requires multi-parameter analysis:

Experimental design components:

• Comparative stimulation: Parallel treatment of cells with:

  • IL-12 alone (optimal concentration: 10 ng/mL)

  • IFN-α alone (100-1000 IU/mL)

  • Combined IL-12 + IFN-α

  • Time course analysis (5, 15, 30, 60 minutes)

• Multi-parameter readouts:

  • Phospho-STAT4 detection by Western blot and flow cytometry

  • Total STAT4 expression levels

  • Downstream gene expression (IFN-γ, T-bet)

  • Functional assays (T cell differentiation, proliferation)

• Species-specific considerations:

  • Use both human and mouse cells to examine species differences

  • For human studies: Peripheral blood CD4+ T cells or NK cells

  • For mouse studies: Splenic T cells, purified CD4+ cells

Analytical approaches:

• Quantitative analysis: Densitometry of Western blots to measure phosphorylation intensity

• Kinetic profiling: Temporal analysis to detect differences in activation/deactivation rates

• Inhibitor studies: JAK inhibitors can distinguish receptor-specific pathways

• Genetic approaches: siRNA knockdown of specific JAK family members

Interpreting results:
Research has demonstrated that in mouse T cells, IFN-α induces weaker and more transient STAT4 phosphorylation than IL-12, with minimal contribution to Th1 development. In contrast, IFN-α effectively promotes Th1 development in human CD4+ T cells through STAT4 activation . These differences highlight the importance of species-specific analysis and caution against extrapolating results between species.